Eagle's Eye View: Your Weekly CV Update From ACC.org (Week of Sept. 20)
This week's View summarizes articles on empagliflozin improving CV outcomes irrespective of blood pressure, the efficacy of the COVID-19 vaccine at 6 months post-vaccination, and the protection of the COVID-19 booster dose in Israel.
Clinical Topics: Arrhythmias and Clinical EP, Cardiovascular Care Team, Congenital Heart Disease and Pediatric Cardiology, Diabetes and Cardiometabolic Disease, Geriatric Cardiology, Heart Failure and Cardiomyopathies, Prevention, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Prevention, CHD and Pediatrics and Quality Improvement, Acute Heart Failure
Keywords: EaglesEyeView, Blood Pressure, Glomerular Filtration Rate, Glucosides, Heart Failure, Hypotension, Kidney Transplantation, Metabolic Syndrome, Primary Prevention, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Stroke Volume, Adolescent, Coronavirus, COVID-19, ACC COVID-19 Podcast, COVID-19 Vaccines, Risk Factors, RNA, Messenger, SARS-CoV-2, Vaccination, Vaccine Potency, Aged, Critical Illness, Israel, RNA, Messenger, Stored, Vaccines, Arrhythmias, Cardiac, Patient Care Team, Heart Defects, Congenital, Geriatrics
< Back to Listings